Active Ingredient: LEFAMULIN ACETATE
Proprietary Name: XENLETA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 600MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N211672
Product Number: 001
Approval Date: Aug 19, 2019
Applicant Holder Full Name: NABRIVA THERAPEUTICS IRELAND DAC
Marketing Status:
Prescription
Patent and Exclusivity Information
